LivaNova (LIVN) Interest & Investment Income (2014 - 2021)
LivaNova (LIVN) reported Interest & Investment Income of $142000.0 for Q4 2021, up 140.46% on a YoY basis from $59054.5 in Q4 2020, and down 20.22% sequentially from $178000.0 in Q3 2021.
LivaNova (LIVN) Interest & Investment Income (2014 - 2021) Analysis & Trends
LivaNova (LIVN) has 8 years of Interest & Investment Income data on file, last reported at $142000.0 in Q4 2021.
- For the quarter ending Q4 2021, Interest & Investment Income rose 140.46% year-over-year to $142000.0; the trailing twelve-month figure through Dec 2021 stood at $509000.0 (up 288.55% YoY), and the FY2021 full-year result was $435000.0, up 232.06% from the prior year.
- Interest & Investment Income fell to $142000.0 in Q4 2021, from $178000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $594000.0 in Q4 2017 to a low of -$351000.0 in Q4 2020.
- A 5-year average of $189894.7 and a median of $189000.0 in 2021 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 1218.75% in 2019 and sank 296.09% in 2020, its largest moves.
- Tracing LIVN's Interest & Investment Income over 5 years: stood at $594000.0 in 2017, then sank by 102.69% to -$16000.0 in 2018, then surged by 1218.75% to $179000.0 in 2019, then slumped by 296.09% to -$351000.0 in 2020, then soared by 140.46% to $142000.0 in 2021.
- Business Quant data shows LIVN's Interest & Investment Income at $142000.0 in Q4 2021, $178000.0 in Q3 2021, and $189000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 142,000.00 |
| Sep 30, 2021 | 178,000.00 |
| Jun 30, 2021 | 189,000.00 |
| Dec 31, 2020 | -351,000.00 |
| Sep 30, 2020 | 47,000.00 |
| Jun 30, 2020 | 287,000.00 |
| Mar 31, 2020 | 148,000.00 |
| Dec 31, 2019 | 179,000.00 |
| Sep 30, 2019 | 151,000.00 |
| Jun 30, 2019 | 224,000.00 |
| Mar 31, 2019 | 249,000.00 |
| Dec 31, 2018 | -16,000.00 |
| Sep 30, 2018 | 184,000.00 |
| Jun 30, 2018 | 232,000.00 |
| Mar 31, 2018 | 447,000.00 |
| Dec 31, 2017 | 594,000.00 |
| Sep 30, 2017 | 199,000.00 |
| Jun 30, 2017 | 252,000.00 |
| Mar 31, 2017 | 273,000.00 |
| Dec 31, 2016 | 579,000.00 |